THP-1 reference data: Proposal of an in vitro branched evolution model for cancer cell lines

Fumio Kasai1,2, Noriko Hirayama2, Makoto Fukushima1

  • 1RIKEN Cell Bank, Cell Engineering Division, BioResource Research Center, Tsukuba, Japan.

Insights

Four THP-1 leukemia cell line sublines show significant genomic and transcriptomic differences due to genetic drift. RCB3686 is closest to the original THP-1, making it an optimal model for AML-M5 research.

Area of Science:

  • Cell Biology
  • Genomics
  • Cancer Research

Background:

  • THP-1 is a widely used leukemia cell line, registered under multiple accession numbers.
  • Previous studies have not clarified the genetic differences between these THP-1 sublines.
  • Understanding these variations is crucial for reproducible leukemia research.

Purpose of the Study:

  • To comprehensively compare four distinct THP-1 cell line sublines at chromosomal and DNA sequence levels.
  • To identify the subline closest to the original THP-1 for AML-M5 modeling.
  • To provide a reference for classifying THP-1 progenies.

Main Methods:

  • Chromosome analysis to determine ploidy.
  • Target sequencing to analyze variant frequencies.
  • SNP microarrays to assess genetic profiles and loss of heterozygosity.
  • Short tandem repeat (STR) genotyping for subtle genetic distinctions.
  • Transcriptome analysis to compare gene expression patterns.

Main Results:

  • Significant differences in ploidy were observed: JCRB0112 (triploid) and RCB1189 (tetraploid).
  • SNP microarrays revealed four distinct profiles with large-scale loss of heterozygosity.
  • Transcriptome analysis indicated JCRB0112.1 diverged significantly from the other three lines.
  • RCB3686 was identified as the most genetically similar to the original THP-1.
  • All four sublines exhibited unique variant frequency patterns and STR genotypes.

Conclusions:

  • The four THP-1 sublines represent independent lineages with substantial genomic and transcriptomic divergence.
  • Genetic drift significantly influences gene expression in cell line subcultures.
  • RCB3686 is recommended as an optimal model for Acute Myeloid Leukemia subtype M5 (AML-M5).
  • STR marker comparison is proposed as a reliable method to distinguish THP-1 sublines.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cell Lines01:16

Cell Lines

A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
8.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K